Mifepristone is 1 of the medications indicated for the treatment of ACTH-independent endogenous Cushing syndrome, especially when surgery is delayed or contraindicated. The gene discussed is POMC; the disease is Cushing syndrome due to macronodular adrenal hyperplasia.